Physician profile
Mohammad Anadani
NPI 1407237977
$3,475.32
in general payments reported to CMS, 2019-2025
6 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,793 · 2022: $84.15 · 2023: $1,005 · 2024: $227 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $805 · Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $805.14 |
| Food and Beverage | $792.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,914.21 | 2021-2024 | Target |
| Medtronic, INC. | $852.72 | 2022-2025 | Kyphon Express II Kyphopak Tray, Cd Horizon Spinal System |
| Depuy Synthes Sales INC. | $535.84 | 2022-2025 | Embotrap, N/A, Trufill |
| Penumbra, INC. | $128.93 | 2025 | Penumbra System |
| Microvention, INC. | $26.82 | 2021 | |
| Abbvie INC. | $16.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Anadani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.